The Antithrombotic Conundrum
Created for Biotechnology client
The paradox that thrombosis can be simultaneously dangerous and necessary has proven difficult to convey to an audience of biotechnology investors. During procedures such as angioplasty, blood clotting must be controlled with anticoagulants to prevent ischemia. However, when the procedure is complete, clotting is vital to prevent bleeding, and is an essential part of the healing process.